The new hire, who has clients in pharma and medical devices and diagnostics, will lead the firm’s IP & Technology practice ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners ...

The seasoned IP leader has left biotech GRAIL to expand the firm’s capabilities in life sciences, technology, and AI in ...

The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich. Already ...

Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences ...

New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation ...

Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as ...

A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates ...

27 January 2026 As quantum-enabled innovation accelerates, patentability will hinge on predictability, disclosure, and ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content. For more information on individual ...

The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent. Already registered?